As of June 2025, the peer review of all NINDS applications for grants, cooperative agreements, and research and development contracts have been centralized within NIH’s Center for Scientific Review (CSR).
NeuroNEXT, StrokeNet, and URGenT applications in response to a Research Opportunity Announcement (ROA) are managed under NIH's Other Transaction Authority (OTA). The reviews are be objectively evaluated at NINDS under the supervision of Dr. Shantadurga Rajaram, Acting Chief and Acting Deputy Director, Division of Extramural Activities (DEA), NINDS.
OT Evaluation Team:
Health Science Administrators: Pragya Prakash, Ph.D. and Shantadurga Rajaram Ph.D.
Special Emphasis Panel: ZNS1 SRB V or ZNS1 SRB G
Program Specialist: Lakashea McKoy